Condition : Rheumatoid Arthritis Interventions : Drug: SAR153191 (REGN88); Drug: placebo Sponsors : Sanofi-Aventis; Regeneron Pharmaceuticals Recruiting - verified August 2011

This is an extension study for subjects who participated in Protocol 20090061. All subjects in this study will receive a 210mg injection of AMG827 for treatment for their Rheumatoid Arthritis for up t...

Condition : Rheumatoid Arthritis Interventions : Drug: Placebo; Drug: VX-509; Drug: VX-509; Drug: VX-509; Drug: VX-509 Sponsor : Vertex Pharmaceuticals Incorporated Completed - verified August 2011

Condition : Rheumatoid Arthritis Interventions : Drug: Placebo; Drug: VX-509; Drug: VX-509; Drug: VX-509; Drug: VX-509 Sponsor : Vertex Pharmaceuticals Incorporated Completed - verified August 2011

Condition : Rheumatoid Arthritis Interventions : Drug: CAM3001; Drug: CAM3001; Drug: CAM3001; Drug: CAM3001 Sponsors : MedImmune LLC; MedImmune Ltd Recruiting - verified August 2011

Conditions : Hallux Limitus; Hallux Rigidus Interventions : Radiation: Joint Resection- Keller Procedure; Procedure: Joint Fusion; Procedure: Hemi-metallic Joint Implant Sponsor : American College of...

Condition : Rheumatoid Arthritis Intervention : Drug: tocilizumab [RoActemra/Actemra] Sponsor : Hoffmann-La Roche Recruiting - verified July 2011

This study is designed to compare the effectiveness of the experimental drug, CP-690,550, to methotrexate in preventing joint damage and improving symptoms of rheumatoid arthritis. This study will als...

This study is designed to compare the effectiveness of the experimental drug, CP-690,550, to methotrexate in preventing joint damage and improving symptoms of rheumatoid arthritis. This study will als...

Conditions : Osteoarthritis; Knee Replacement Intervention : Sponsors : Coxa, Hospital for Joint Replacement; University of Tampere; Seinajoki Central Hospital Recruiting - verified August 2011